Macquarie Park’s newest RNA pilot research and manufacturing facility

Written by

Charbel Abousleiman
Urban Planning Lawyer & Buyers Agent

11/09/2023

Health Infrastructure NSW is proposing to develop and operate a RNA (ribonucleic acid) pilot research and manufacturing facility on Macquarie University’s campus at the corner of Gymnasium Road and Colloden Road.

At present, the development site comprises an at-grade carpark with 258 spaces, which services the Macquarie University Sports and Aquatic Centre.

The proposal will build and diversify the research and development and medical manufacturing industry in NSW to ensure that future diagnostic health emergencies can be addressed. Opportunities will be provided for personalised treatments for cancers, as well as genetic and infectious diseases.

Health Infrastructure will utilise a suite of emerging biotechnologies, centralise RNA knowledge, expertise and manufacturing in a single location and create highly skilled jobs in an existing health and education precinct.

Ryde Council’s Contributions Plan will not apply to the proposal. Instead, Health Infrastructure will execute a voluntary planning agreement with Ryde Council and Macquarie University.

Project site and its context

The NSW government is committed to establishing a RNA pilot research and manufacturing facility, which will translate research into a sustainable commercial pipeline of RNA therapeutics and products. This unique facility will undertake significant health research and manufacture potential RNA therapeutics, including vaccines. The facility will have the potential to increase to population-scale production of vaccine or other medical therapeutics.

RNA is a linear molecule that can be represented as a sequence of letter. It is an emerging technology, and the world is playing catch up on the development of infrastructure, expertise and resources to try and capture a share within the new market. RNA is single-stranded and has the nitrogenous base uracil instead of thymine. It is made of DNA and has many functions, including helping to manufacture proteins.

The facility will be governed by a not-for-profit partnership – RNA Australia Limited – whose partners comprise the NSW government and universities.

Subscribe to

Macquarie Park: Lachlan’s Line Grows 24 Storeys Taller
As part of the broader vision for Lachlan’s Line, a 24-storey residential development project has been approved at 3 Halifax Street in Macquarie Park….
Centuria’s Wetherill Park Gem: Redefining Industrial Standards
In the bustling heart of Wetherill Park’s established industrial precinct, a remarkable transformation is taking place….
Breaking Bureaucratic Gridlock to Build Rydalmere’s Future
The NSW Government has launched an ambitious plan to transform the long-vacant 19.4-hectare Rydalmere site into a vibrant mixed-use precinct, aiming to deliver about 2,300…

Talk to us

+61 416 618 244

Find us

Australia Square

Level 44, 264 George Street

Sydney NSW 2000

Mon-Fri: 9am – 5pm | Sat-Sun: Closed

Subscribe to

Propertied Insider is a planning and development digital publication dedicated to the NSW Market.